Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
CORDLIFE Group said on Tuesday that it has rejected an unsolicited third party offer for its shares in China Cord Blood Corporation and convertible notes due 2017. Instead, it will proceed with an earlier plan to sell them to Hang Seng-listed healthcare...